PFN1 and head and neck squamous cell carcinoma: Therefore, the assessment of the number of PFN1+CD326+ CTCs in the peripheral blood of HNSCC patients can determine the presence of lymph node metastases with a sensitivity of 85% and a specificity of 96%.